Biotech | March 23, 2022
GMP certification for Exothera further extends its viral vector manufacturing capacity
The expansion makes Exothera one of the largest viral vector facilities in Europe
The expansion makes Exothera one of the largest viral vector facilities in Europe
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025
New data, including two late-breaking clinical trial presentations on mavacamten and a new analysis of the GUARD-AF study, reinforce the company’s continued commitment to those living with cardiovascular disease
She joined Trivitron Healthcare in 1999 and has held several positions in the organisation
Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now
Divsa's coverage across Central America bridges Barentz' leading positions in North and South America
Enables millions of Indians to monitor their vitals without the need of any additional device
The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines
Nasonex is a registered trademark of Organon and is used by Perrigo and its affiliates under license
Inconsistent antibody performance is a significant challenge for researchers and sits at the heart of the reproducibility crisis observed in biomedical research
Subscribe To Our Newsletter & Stay Updated
